QRS interval (milliseconds) | QTc interval (milliseconds) | PR interval (milliseconds) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Model | HIV/treatment group | Mean difference | 95% CI | p Value | Mean difference | 95% CI | Mean difference | 95% CI | p Value | ||
Crude | Non-HIV | Ref | Ref | Ref | |||||||
ART-naïve HIV | All 37 | 2.9 | −2.6 to 8.3 | 0.31 | 14.0 | 3.8 to 2.3 | <0.001 | 8.3 | −2.1 to 18.6 | 0.12 | |
32 Never ART | 2.5 | −3.2 to 8.1 | 0.39 | 11.5 | 0.4 to 22.5 | 0.04 | 4.7 | −6.1 to 15.5 | 0.39 | ||
ART-exposed HIV | −0.4 | −5.7 to 4.8 | 0.90 | 26.2 | 16.7 to 35.6 | <0.001 | 3.4 | −6.1 to 12.9 | 0.49 | ||
RR interval adjustment | Non-HIV | Ref* | |||||||||
ART-naïve HIV | All 37 | 9.2 | −1.1 to 19.6 | 0.08 | |||||||
32 Never ART | 6.7 | −4.3 to 17.5 | 0.23 | ||||||||
ART-exposed HIV | 4.1 | −5.4 to 13.6 | 0.40 | ||||||||
Model 1 | Non-HIV | Ref | Ref | Ref† | |||||||
ART-naïve HIV | All 37 | 4.6 | −0.8 to 10.1 | 0.10 | 16.9 | 6.7 to 27.1 | <0.001 | 10.5 | −0.03 to 21.0 | 0.05 | |
32 Never ART | 5.2 | −0.7 to 11.0 | 0.09 | 15.7 | 4.5 to 27.0 | <0.001 | 7.8 | −3.6 to 19.2 | 0.18 | ||
ART-exposed HIV | 0.1 | −5.0 to 5.2 | 0.97 | 27.1 | 17.8 to 36.3 | <0.001 | 4.2 | −5.3 to 13.9 | 0.42 | ||
Model 2 | Non-HIV | Ref | Ref‡ | ||||||||
ART-naïve HIV | All 37 | 5.0 | −1.0 to 11.0 | 0.10 | 18.2 | 7.0 to 29.3 | <0.001 | 12.9 | 2.4 to 23.3 | 0.02 | |
32 Never ART | 4.6 | −2.0 to 11.1 | 0.17 | 17.0 | 4.7 to 29.3 | <0.001 | 13.3 | 1.6 to 24.9 | 0.03 | ||
ART-exposed HIV | 0.2 | −5.1 to 5.5 | 0.94 | 28.9 | 19.3 to 38.5 | <0.001 | 4.3 | −4.7 to 13.3 | 0.35 |
Model 1: adjusted for age; model 2: adjusted for age, BMI.
*Adjusted for RR interval.
†Model 1 + adjusted for RR interval.
‡Model 2 + adjusted for RR interval.
ART, antiretroviral therapy; BMI, body mass index.